Literature DB >> 1500066

Kinetic and energetic parameters of imipramine binding to monoclonal antibodies as measured by fluorescence spectroscopy.

D Gabler1, C Mandal, C Harrington, M Adamczyk, D S Linthicum.   

Abstract

Monoclonal antibodies which bind small drugs are useful for the study of the interactive forces involved in antibody-ligand complexation. Detailed understanding of these supramolecular forces requires a careful examination of structural and thermodynamic parameters of the interacting molecules. Fluorescence spectroscopy techniques are very useful in this regard. We report here, the kinetic and energetic parameters of four monoclonal antibodies made against the tricyclic antidepressant imipramine. These monoclonal antibodies were found to possess high to very high binding affinity constants, ranging from 10(7) to 10(10) M-1, and caused fluorescence quenching or enhancement of a fluorescein labelled imipramine. The dissociation rates of the fluorescent ligand from the complexes were measured at different temperatures in order to provide some insight regarding the kinetic and energetic (thermodynamic) parameters of the antibody-ligand binding interactions.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1500066     DOI: 10.1089/hyb.1992.11.301

Source DB:  PubMed          Journal:  Hybridoma        ISSN: 0272-457X


  3 in total

1.  Large cell neuroendocrine carcinoma of the colon: A rare and aggressive tumor.

Authors:  Michael R Pascarella; David McCloskey; Jenia Jenab-Wolcott; Marc Vala; Marc Rovito; James McHugh
Journal:  J Gastrointest Oncol       Date:  2011-12

2.  Spectroscopic evidence for charge-transfer complexation in monoclonal antibodies that bind opiates.

Authors:  P R Droupadi; E A Meyers; D S Linthicum
Journal:  J Protein Chem       Date:  1994-04

3.  Involvement of water molecules in the association of monoclonal antibody HyHEL-5 with bobwhite quail lysozyme.

Authors:  K A Xavier; K A Shick; S J Smith-Gil; R C Willson
Journal:  Biophys J       Date:  1997-10       Impact factor: 4.033

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.